Perficient Launches AI Suite for Medicare Advantage Star Ratings Tied to $13B in Bonuses

Perficient, a consulting firm owned by the Swedish private investor EQT, has released a suite of AI tools for Medicare Advantage plans looking to raise their CMS ratings. Those ratings determine access to more than $13B a year in federal bonus payments. The launch came the day after CMS published its 2027 star ratings. Fewer plans clear the threshold in them.

Why stars are worth billions

Medicare Advantage is the commercial alternative to the government's Medicare program: insurance plans receive fixed payments from the government for each enrollee. Quality is rated on a scale of one to five stars. Plans with high ratings (the usual benchmark is four stars and above) receive bonus payments. Insurers often put that money toward lower premiums and extra benefits, in other words, toward attracting customers.

The rating draws on dozens of measures: clinical metrics such as screening programs, member satisfaction surveys, call center speed, and medication adherence. A plan that loses even half a star can lose a noticeable share of its revenue. That is why an industry of consultants and software focused solely on stars has existed in this market for a long time.

What we know about the product

The published announcement says little: it is an AI suite, and its job is to help plans improve the measures that drive their CMS ratings. The available material does not say which modules the package includes, which models it is built on, whether it uses large language models or classical machine learning, how much it costs, or who the first customers are. There are also no claims of measured rating gains.

Key facts as of today:

• Vendor: Perficient, owned by EQT
• Target customer: Medicare Advantage plans
• Goal: raising CMS star ratings
• Money at stake: more than $13B a year in bonus payments
• Trigger: publication of the 2027 ratings, in which fewer plans qualified
• Launch date: October 9, 2026
• Not disclosed: architecture, pricing, customers, verified results

Timing and EQT's role

The overlap with the ratings release is unlikely to be a coincidence. When CMS publishes its scores, insurers get a concrete list of failures, and with it a budget and a sense of urgency. A vendor that arrives with a product the next day is selling at the moment of the customer's greatest anxiety.

The owner deserves a separate mention. According to reports on the deal, EQT bought Perficient in 2024 at a valuation of about $3B. Funds of this type look for vertical products with recurring revenue rather than one-off integration projects. An industry-specific AI package for healthcare with a clear dollar link, where every star is measured in dollars, fits that logic. This is our interpretation, not a statement from the company.

Practical advice for buyers

Plans considering tools like this have several things to check before signing a contract.

• The ratings cycle is long. Scores rely on data from earlier years, so a decision made in autumn 2026 will most likely not affect ratings before 2028–2029. Ask the vendor which measures it can move faster.
• Demand a metric-by-metric breakdown. A generic promise to "raise the rating" is worth nothing; you need ties to specific measurable indicators and a baseline.
• Clarify how personal health data is handled: where it is processed, which models see it, and how auditing works.
• Ask for explainability. If the AI prioritizes which members to call or remind, the compliance team must understand the selection criteria.
• Tie payment to results. With billions of dollars at stake, the vendor should have no trouble sharing part of the risk with the client.

The main question for Perficient remains open: will public case studies with numbers appear? Until they do, this is a bid for the market, not a proven tool.